References
- Kulier R, Helmerhorst F M, O'Brien P, et al. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 2006; 3, CD005347
- National Institute of Clinical Excellence (NICE). CG 30 Long-acting Reversible Contraception: The effective and appropriate use of long-acting reversible contraception, Full Guideline; October 2005, Accessed 10 March 2008 from: http://www.nice.org.uk/guidance/index.jsp
- Otero-Flores J B, Guerrerro-Carreno F J, Vazquez-Estrada L A. A comparative randomized study of three different IUDs in nulliparous Mexican women. Contraception 2003; 67: 273–276
- Lete I, Morales P, de Pablo J L. Use of intrauterine contraceptive devices in nulliparous women: Personal experience over a 12-year period. Eur J Contracept Reprod Health Care 1998; 3: 190–193
- Dennis J, Webb A, Kishen M. Introduction of the GyneFix intra-uterine device into the UK: Client satisfaction survey and case notes review. J Fam Plann Reprod Health Care 2001; 27: 139–144
- Suhonen S, Haukkamaa M, Jakobsson T, et al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 2004; 69: 407–412
- Department of Health. Abortion Statistics, England and Wales: 2006, Statistical Bulletin 2006/01 (London: DH, 2007). Accessed 31 October 2007 from: http://www.dh.gov.uk
- Petersen K R, Brooks L, Jacobsen B, et al. Intrauterine devices in nulliparous women. Adv Contracept 1991; 7: 333–338
- Tinelli A, Tinelli R, Malvasi A, et al. The intrauterine device in modern contraception: Still an actuality?. Eur J Contracept Reprod Health Care 2006; 11: 197–201
- Veldhuis H M, Vos A G, Lagro-Janssen A L. Complications of the intrauterine device in nulliparous and parous women. Eur J General Practice 2004; 10: 82–87
- Ramirez Hidalgo A, Pujol Ribera E. Use of the intrauterine device: Efficacy and safety. Eur J Contracept Reprod Health Care 2000; 5: 198–207
- Dueñas J L, Albert A, Carrasco F. Intrauterine contraception in nulligravid vs parous women. Contraception 1996; 53: 23–24
- World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use. WHO, GenevaSwitzerland 2004
- UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2005/2006), Accessed 31 October 2007 from: http://www.ffprhc.org.uk/admin/uploads/298-UKMEC-200506.pdf
- Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception 2007; 75: S8–S11
- FSRH Guidance (November 2007) Intrauterine contraception, Accessed 18 March 2008 from: www.ffprhc.org.uk/admin/uploads/CEUGuidanceIntrauterineContraceptionNov07.pdf